eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
4/2024
vol. 11
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł przeglądowy

Research progress on free fatty acid receptors and bronchial asthma

Fangxin Cao
1
,
Na Lin
1
,
Juntao Lin
1
,
Gai Yang
1
,
Xintong Wang
1

  1. Department of Pediatrics, Youjiang Medical University for Nationalities, Baise, China
Alergologia Polska – Polish Journal of Allergology 2024; 11, 4: 322–326
Data publikacji online: 2024/09/19
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Bronchial asthma is a chronic respiratory disease characterized by reversible airflow limitation, including airway hyperresponsiveness, airway inflammation and airway remodeling. The clinical manifestations are recurrent tachypnea, wheezing, dyspnea, cough and other manifestations, which seriously affect the life of patients. The incidence of asthma increases the social and economic burden. Many researchers have reported the role of free fatty acid receptors (FFARs) in diseases such as bronchial asthma, colitis, arthritis and other diseases. Free fatty acids are ligands of FFARs. GPR40, GPR41, GPR43, GPR120 and GPR84 have been identified as FFARs. There are many studies on fatty acids and asthma. However, whether this represents the role of FFARs needs further study. FFARs can affect the occurrence and progression of asthma through β-arrestins, RhoA/ROCK1, PLC/IP3, MAPK, AMPK and other pathways. This article reviews the research progress on the role of FFARs in bronchial asthma, with the aim of providing a reference for their use as new targets for the treatment of bronchial asthma.


© 2024 Termedia Sp. z o.o.
Developed by Bentus.